Riskpilot← Back to searchSign inGet full accessAdmiloma AB
ABActiveOrg 5568757628Råsundavägen 74Physiotherapy activities · NACE 8695Est. 20111-4 employees
Revenue 2024
SEK 1,1M
+9% vs 2023
EBITDA margin
-5.5%
-259% vs 2023
Equity ratio
76.5%
Financial strength
Net profit 2024
SEK -64K
-346% vs 2023
| Revenue | SEK 1,1M | +9% |
| EBITDA | SEK -62K | -259% |
| Net profit | SEK -64K | -346% |
| Total assets | SEK 311K | -15% |
| Equity | SEK 238K | -21% |
| Employees | — | — |
Legal name
Admiloma AB
Org number
5568757628
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
12 december 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukgymnastikverksamhet, handel samt förvaltning av värdepapper, aktier, fastigheter och tomter samt idka därmed förenlig verksamhet.
Address
Råsundavägen 74
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 355 | 1 045 | 1 033 | 1 124 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −10 | 233 | 55 | 39 | −62 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −10 | 233 | 55 | 39 | −62 |
| Net financials | — | — | −4 | −4 | −3 |
| Profit before tax | −10 | 233 | 51 | 35 | −64 |
| Tax | −0 | −34 | −12 | −9 | −0 |
| Net profit | −10 | 199 | 39 | 26 | −64 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 53 | 338 | 407 | 368 | 311 |
| Equity | 38 | 237 | 276 | 302 | 238 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 15 | 100 | 130 | 66 | 73 |
| Total debt | 15 | 100 | 130 | 66 | 73 |
EBITDA margin
-5.5%
This company
15.8%
Market median
-135% vs market
20202024
Equity ratio
76.5%
This company
38.2%
Market median
+100% vs market
20202024
Return on equity
-26.9%
This company
18.4%
Market median
-246% vs market
20202024
Net profit margin
-5.7%
This company
8.1%
Market median
-170% vs market
20202024
Asset turnover
3.61×
This company
1.12×
Market median
+222% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Admiloma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Mikael Johannesson | Board of Directors | 0 companies |
| Sara Marielle Fond Kerber | Deputy Board Member | 0 companies |
| Carolina Maria Gonzalez | Board of Directors | 0 companies |
| Johan Sebastian Zetterlund | Deputy Board Member | 0 companies |